More than 200 cases of monkeypox worldwide: EU disease agency

The number of confirmed cases of monkeypox worldwide has reached 219 outside of countries where it is endemic, according to an update released by the European Union‘s disease agency.

More than a dozen countries where monkeypox is unusual, mostly in Europe, have reported at least one confirmed case, the European Centre for Disease Prevention and Control (ECDC) said in an epidemiological note released Wednesday night.

“This is the first time that chains of transmission are reported in Europe without known epidemiological links to West or Central Africa, where this disease is endemic,” the note said.

It added that most of the cases were detected in young men, self-identifying as men who have sex with men.

The United Kingdom — where monkeypox’s unusual appearance was first detected in early May — currently has the largest bulk of confirmed cases, 71.

It is followed by Spain with 51 cases and Portugal, 37.

Outside of Europe, Canada has 15 and the United States has nine.

The total number of cases reported Wednesday has increased fivefold since its first count on May 20, when the EU agency said there were 38 cases.

Contagion risk is “very low”, the ECDC said earlier this week, but warned that people who have had multiple sexual partners — regardless of sexual orientation — are more at risk.

“The clinical presentation is generally described to be mild,” it said, adding that there has been no deaths.

Monkeypox — a less severe disease compared to its cousin smallpox — is endemic in 11 countries in West and Central Africa.

It spreads by a bite or direct contact with an infected animal’s blood, meat or bodily fluids, and initial symptoms include a high fever before quickly developing into a rash.

People infected with it also get a chickenpox-like rash on their hands and face.

No treatment exists but the symptoms usually clear up after two to four weeks, and it is not usually fatal.

Maria Van Kerkhove, the emerging disease lead for the World Health Organization, said Monday that monkeypox is a “containable situation”.

  • Related Posts

    Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

    US President Donald Trump on Monday said nine pharmaceutical manufacturers, including Sun Pharma, have reached agreements with his administration to lower prescription drug prices for Americans in line with the…

    FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test

    Mumbai: The Maharashtra Nodal Cyber Police have registered an FIR against 22 foreign medical graduates for allegedly uploading fake and suspicious documents on Maharashtra Medical Council (MMC) portal to obtain…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

    Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

    FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test

    FIR against 22 foreign medical graduates for uploading fake docus on Maharashtra Medical Council portal to obtain temporary registration without clearing screening test

    FUJIFILM India is zeroing in on Indian Gut with Advanced Therapeutic Endoscopy

    FUJIFILM India is zeroing in on Indian Gut with Advanced Therapeutic Endoscopy

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government